The global obesity treatment devices market expected to reach US$ 3.2 billion by 2023, growing at CAGR 10.5% over the forecast period 2018-2023.
Visit the global obesity treatment devices market by device type (gastric banding systems, gastric balloon systems, gastric electrical stimulation systems, gastric emptying systems or gastric aspiration systems, other emerging devices – endoluminal bypass liners, oral appliances); and surgery procedure (Roux-en-Y gastric bypass surgery, adjustable gastric band, laparoscopic sleeve gastrectomy, biliopancreatic diversion with duodenal switch, revisions, other surgical procedures), by geography and forecast 2015-2023 at https://www.ihealthcareanalyst.com/report/obesity-treatment-devices-market/
The global obesity treatment devices market research report provides market size (Revenue US$ Million 2015 to 2023), market share analysis, growth trends and forecast (CAGR%, 2018 to 2023). The global obesity treatment devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global obesity treatment devices market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.
Major players include Allergan, Inc., Apollo Endosurgery, Inc., Aspire Medical, Inc. (Aspire Bariatrics), Boston Scientific Corp., Cousin Biotech, CR Bard, Inc., EnteroMedics, Inc., GI Dynamics, Inc., GI Windows, Inc., Johnson & Johnson, Leptos Biomedical, Mediflex Surgical Products, Medtronic, Inc., ReShape Medical, Inc., Satiety, Inc., Spatz FGIA, Inc., and TransEnterix, Inc.
1. Device Type
1.1. Gastric Banding Systems
1.2. Gastric Balloon Systems
1.3. Gastric Electrical Stimulation Systems
1.4. Gastric Emptying Systems (Gastric Aspiration Systems)
1.5. Other Emerging Devices (Endoluminal bypass liners, Oral appliances)
2. Surgery Procedure
2.1. Roux-en-Y Gastric Bypass Surgery (RNY)
2.2. Adjustable Gastric Band
2.3. Laparoscopic Sleeve Gastrectomy
2.4. Biliopancreatic Diversion with Duodenal Switch (BPD/DS)
2.6. Other Surgical Procedures
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC
3.5. Rest of the World
4. Company Profiles
4.1. Allergan, Inc.
4.2. Apollo Endosurgery, Inc.
4.3. Aspire Medical, Inc. (Aspire Bariatrics)
4.4. Boston Scientific Corp.
4.5. Cousin Biotech
4.6. CR Bard, Inc.
4.7. EnteroMedics, Inc.
4.8. GI Dynamics, Inc.
4.9. GI Windows, Inc.
4.10. Johnson & Johnson
4.11. Leptos Biomedical
4.12. Mediflex Surgical Products
4.13. Medtronic, Inc.
4.14. ReShape Medical, Inc.
4.15. Satiety, Inc.
4.16. Spatz FGIA, Inc.
4.17. TransEnterix, Inc.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043